Adipose-derived stem cells for breast reconstruction after breast surgery - preliminary results.
Tsekouras A., Mantas D., Tsilimigras DI., Ntanasis-Stathopoulos I., Kontos M., Zografos GC.
Prospective Study, published in Case Reports Plast Surg Hand Surg (2017) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- Case Reports Plast Surg Hand Surg (2017)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 28470033
- PMCID
- PMC5404643
- DOI
- 10.1080/23320885.2017.1316201
- Citations
- 5
Abstract (original English)
Enrichment of fat grafts with adipose-derived stem cells (ASCs) has gained popularity due to promising preliminary results. Herein, we present two patients who were treated with ASC-enriched fat grafts following mastectomy and breast reconstruction with implants. Both exhibited favorable outcomes achieving a significant improvement of breast defects and asymmetries.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.